Cranial stereotactic radiotherapy in central nervous system hemangioblastoma, state of the art.

Abstract

Hemangioblastoma (HB) is a benign tumor of the central nervous system, in some cases, its growth makes it behave aggressively due to the mass effect it exerts on nearby structures; it can occur sporadically or as associated with Von Hippel Lindau disease (VHL); the treatment of preference for sporadic HB is surgical resection, however, for those associated with VHL, radiotherapy has proven to be an effective treatment. In the last decades with the advances in new radiotherapy techniques, such as cranial stereotactic radiotherapy; it has been possible to increase the dose directed to these lesions, being an effective treatment, with significant disease control rates and with acceptable toxicity, so it is relevant to know and apply this type of treatments. It is for this reason that a narrative review on this subject, in the Centro Medico Docente La Trinidad, gives us an adequate and updated knowledge on the effective and safe treatment of this pathology, allowing the use of this modality in our country, for the good of our patients.